News & Updates
Showing Gastroenterology articles
Showing
Show Multimedia Only

Treatment failure risk in older IBD patients higher with vedolizumab vs TNF antagonists
25 Oct 2022
The use of vedolizumab in the treatment of older patients with inflammatory bowel disease (IBD) appears to not only pose a higher risk of treatment failure but also offer no significant safety advantage when compared with tumour necrosis factor (TNF) antagonists, according to a study.
25 Oct 2022

Potassium competitive acid blockers go toe-to-toe with PPI in gastric acid diseases
21 Oct 2022
byTristan Manalac
Vonoprazan, a potassium competitive acid blocker (PCAB), is better than proton pump inhibitors (PPI) for the treatment of Helicobacter pylori and erosive oesophagitis, according to a new meta-analysis.
21 Oct 2022






